Skip to content

Clinical Efficacy Study of "Tong Shu Yi Nao" Acupuncture Intervention for Post-Stroke Cognitive Impairment

Clinical Efficacy Study of "Tong Shu Yi Nao" Acupuncture Intervention for Post-Stroke Cognitive Impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000575
Enrollment
Unknown
Registered
2025-03-22
Start date
2025-04-19
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke cognitive impairment

Interventions

treatment group:"Tong Shu Yi Nao" Acupuncture Treatment+Pharmacotherapy + Conventional Treatment
control group:Pharmacotherapy + Conventional Treatment

Sponsors

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the aforementioned diagnostic criteria; (2) Both genders are eligible aged between 35 and 75 years; (3) Cognitive impairment occurs within 6 months after stroke and persists for more than 3 months excluding other causes; (4) Montreal Cognitive Assessment (MoCA) score 17 for those without formal education (illiterate) >20 for primary school education and >24 for secondary education and above; (5) Barthel Index (BI) score = 60; (6) No acupuncture treatment received within the past month;(7) The patient or their family members have signed the informed consent form and are cooperative with the treatment.

Exclusion criteria

Exclusion criteria: (1) Patients with cognitive impairment prior to the onset of the stroke; (2) Patients with significant functional abnormalities in important organs such as the heart lungs liver and kidneys as well as in the hematopoietic system; (3) Patients with a history of diseases such as encephalitis epilepsy or other conditions that can cause dementia; (4) Patients with moderate to severe cognitive impairment who are unable to cooperate in completing the examinations; (5) Patients who are allergic to the medications used in the study or who cannot tolerate acupuncture have poor compliance or low tolerance. Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment;

Secondary

MeasureTime frame
Event related potential(P300);Behavior experiment;Minimum Mental State Examination;Stroke Specific Quality of life scale;Activity of Daily Living;

Countries

China

Contacts

Public ContactBo Li

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. The National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion

ibou119@163.com13323332911

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026